Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).

NCT04566653 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04566653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04566653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 23, 2020
Completion date
January 12, 2022
Enrollment
147 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease + hyperkalaemia +/- heart failure